Venture Kick

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

CERN is an international particle-physics laboratory based in Geneva, Switzerland, and the European Organization for Nuclear Research, conducting fundamental research into the structure of matter by operating the world's largest and most complex scientific instruments, including particle accelerators and detectors, that propel and collide particles to observe their interactions. Established in 1954, CERN provides the infrastructure and environment for high-energy physics research, coordinating collaboration among member states and researchers to explore the basic constituents of the universe.

SightIn Health develops artificial intelligence-powered software for portable ultrasound, providing image analytics, usage guidance, and interpretation to support patient diagnosis. The platform automates quality assessment, ultrasound probe guidance, and image analysis, lowering the skill barrier required to operate ultrasound equipment and capture medical images for diagnostics and prognostics. Founded in 2021 and based in Geneva, Switzerland, SightIn Health targets healthcare providers seeking accurate, AI-assisted medical image analysis.

Exomotion SA is a Swiss company founded in 2018, located in Plan-les-Ouates, Geneva. The company specializes in the development of innovative personal mobility devices that utilize robotics technology. Exomotion's products are designed to enhance omnidirectional movement, featuring electronic movement systems that combine electrical boards with motion sensors and a wheeled mechanism. This technology enables the devices to move in any direction and rotate instantly, significantly improving the user experience. By rethinking the concept of e-mobility, Exomotion aims to enhance mobility solutions with a focus on omnidirectionality and safety.

Terapet specializes in advanced proton therapy for cancer treatment. Founded by physicists Christina Vallgren, Marcus Palm, and Professor Raymond Miralbell from Geneva University Hospitals, the company offers precise radiotherapy that minimizes harm to healthy cells. Incorporated in 2019, Terapet is based in Geneva, Switzerland.

Endotelix is a Swiss biotechnology company and a spin-off from the University of Geneva focused on antiphospholipid syndrome. It develops diagnostic tests and treatment options, aiming to deliver fast, sensitive solutions for the condition. The company provides diagnostic tools, therapies, and supports clinical research to assist clinicians in diagnosing antiphospholipid syndrome and identifying effective treatments.

Endotelix is a Swiss biotechnology company and a spin-off from the University of Geneva focused on antiphospholipid syndrome. It develops diagnostic tests and treatment options, aiming to deliver fast, sensitive solutions for the condition. The company provides diagnostic tools, therapies, and supports clinical research to assist clinicians in diagnosing antiphospholipid syndrome and identifying effective treatments.

Shematic is a company founded in Geneva in 2018 that specializes in providing customized electric powertrains for a variety of vehicle manufacturers, including those producing passenger cars, leisure vehicles, and commercial transport. The company aims to facilitate the transition to electric mobility by offering tailored solutions that meet specific performance requirements, with power outputs ranging from 1kW to 500kW. Leveraging its extensive expertise in electric mobility, Shematic also delivers consulting services to assist clients in implementing production processes, as well as designing and manufacturing approved electric motors and battery packs. This diverse skill set positions Shematic as a comprehensive partner for manufacturers seeking to enhance their vehicle traction systems and electrical networks, ultimately supporting their electric mobility projects both in Switzerland and internationally.

Endotelix is a Swiss biotechnology company and a spin-off from the University of Geneva focused on antiphospholipid syndrome. It develops diagnostic tests and treatment options, aiming to deliver fast, sensitive solutions for the condition. The company provides diagnostic tools, therapies, and supports clinical research to assist clinicians in diagnosing antiphospholipid syndrome and identifying effective treatments.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Exomotion SA is a Swiss company founded in 2018, located in Plan-les-Ouates, Geneva. The company specializes in the development of innovative personal mobility devices that utilize robotics technology. Exomotion's products are designed to enhance omnidirectional movement, featuring electronic movement systems that combine electrical boards with motion sensors and a wheeled mechanism. This technology enables the devices to move in any direction and rotate instantly, significantly improving the user experience. By rethinking the concept of e-mobility, Exomotion aims to enhance mobility solutions with a focus on omnidirectionality and safety.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

ABCDx is a Geneva-based company that develops and validates biomarker panels and related diagnostics for brain injury care. It aims to identify patients at risk of severe long-term complications after traumatic brain injury or stroke and to educate clinicians on using these tests. The company is building a platform that analyzes brain biomarkers from a finger-prick blood sample to enable rapid, point-of-care diagnosis of brain injuries, supporting timely treatment decisions. Founded in 2014 by researchers from the University of Geneva and related institutes, ABCDx translates biomarker discovery and clinical validation into practical tools for stroke and brain injury management.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Imverse is a Swiss-based 3D graphics software company established in 2017. Headquartered in Plan-les-Ouates, Geneva, the company specializes in deploying volumetric technology for Location Based Entertainment (LBE). Imverse offers real-time simulation and modeling tools that transform 2D images into immersive, 3D virtual environments suitable for live streaming, gaming, and remote work applications. The company's core product is a live volumetric video platform designed for enterprise use, enabling organizations to stream real-time three-dimensional holograms using depth cameras and reality capture software.

the fair traveller is an online community platform based in Geneva, Switzerland, founded in 2015. The platform aims to connect travelers with environmentally and socially responsible businesses, enabling users to discover authentic locations such as restaurants, cafés, hotels, and shops that engage in sustainable practices. By allowing users to add reviews and comments, the fair traveller fosters a participative environment where individuals can share their experiences and support establishments committed to positive social and environmental actions. This initiative not only facilitates informed travel choices but also encourages users to contribute to sustainable development while exploring new regions.

Tourmaline is a Swiss interactive studio established in 2015 by Camille Attard, specializing in digital media and game production. The company focuses on creating hybrid products that integrate the tangible and digital realms, enhancing the gaming experience through innovative design. Among its offerings is Onirigami, a mobile adventure game for children that incorporates interactive toys, exemplifying Tourmaline's commitment to blending physical and digital play. The studio aims to provide unique gaming experiences by developing advanced graphical interfaces and multi-device setups, positioning itself at the forefront of the evolving gaming landscape. Operating from Geneva, Tourmaline continues to explore new avenues in game development, fostering creativity and interactivity.

Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

Founded in 2012, Amal Therapeutics is a Swiss biotechnology company focused on developing therapeutic vaccines for oncology using its proprietary cell penetrating peptide platform. Its vaccines aim to activate killer T cells and promote immunological memory, facilitating effective cancer treatment.

Founded in 2012, Amal Therapeutics is a Swiss biotechnology company focused on developing therapeutic vaccines for oncology using its proprietary cell penetrating peptide platform. Its vaccines aim to activate killer T cells and promote immunological memory, facilitating effective cancer treatment.

Citiviz creates smart urban mobility applications & ecosystems for citizens, experts and stakeholders. They like sharing ideas about innovative transportation solutions and sustainable cities! They develop computing and geo-visualization solutions for urban intelligence, spatio-temporal monitoring and decision making. Citiviz is specialized on urban transportation and innovative mobility for sustainable cities. Three products are commercialized: Parking Monitoring, Shared Mobility Monitoring, and Advanced Graph/Spatial Computing Platform. They are a team of experienced and quick study engineers! Citiviz is delivering consulting and business intelligence product for urban mobility, contributing to the next generation of intelligent cities. Their solutions and expertise are used by multinationals, enterprises, SMEs, public institutions, professionals and experts, academics, and R&D groups. Their clients are mainly located in Switzerland, France, Scotland and United Kingdom. Citiviz’ ecosystem and knowledge help them in solving complex problems and in answering urgent needs related to transportation, urban & regional planning, architecture and environmental engineering. Founded in August 2012, Citiviz Sàrl (Citiviz) is a spin-off from Ecole polytechnique fédérale de Lausanne (EPFL) and the Geographic Information Systems Laboratory (LASIG) leaded by Prof. François Golay. Over last 10 years, Citiviz and its international R&D partners have completed different projects in various countries: Québec City, Barcelona, Genève, Portugal, Bagdad, Winterthur, Ljubljana, Nice Côte d'Azur. Based on their solutions, these projects were looking on building better knowledge for actions related to transportation, economic development & management, urban planning and humanitarian crisis analysis.

Andrew Alliance is a Swiss robotics company that designs and commercializes automated liquid-handling solutions for the life sciences sector. The company offers a suite of hardware and software tools, including OneLab, a graphical interface to design liquid-handling workflows; Andrew+, a pipetting robot compatible with conventional electronic pipettes; Pipette, a cloud-enabled device to improve ergonomics and traceability; and Andrew, a portable liquid-handling robot that can operate unattended with manual pipettes. It also provides Andrew Assistant, a protocol-design software to create, verify, and document biology protocols that require quantitative liquid handling. Products are assembled and tested in Switzerland, with service and support based in Geneva and an office in Boston, and are sold directly and through distributor partners internationally. Founded in 2011, Andrew Alliance is an independent Swiss company that combines robotics, vision and software to enable researchers to perform precise, repeatable liquid-handling operations more efficiently, aiming to enhance accuracy and throughput in laboratory workflows.

Gourmetiz is an online platform that connects food producers to a range of consumers. The company was founded in 2011 and is headquartered in Geneve, Europe.

TheFabric Physical Computing, established in 2011 by Dr. Xavier Righetti in Geneva, Switzerland, focuses on creating interactive solutions. These solutions can be tangible, utilizing open hardware systems, or graphical, leveraging open source software. The company's technology includes low-end wireless home automation modules aimed at enhancing energy efficiency and comfort for clients, ultimately driving growth and revenue.

Neurix specializes in neurotropic drug development and offers drug discovery services using human stem cell-based models. Its key offerings include MiniBrains, an innovative in vitro neural tissue model in 3D, along with personalized services for assessing drug efficiency on tumor growth, motility, and metastasis.

Andrew Alliance is a Swiss robotics company that designs and commercializes automated liquid-handling solutions for the life sciences sector. The company offers a suite of hardware and software tools, including OneLab, a graphical interface to design liquid-handling workflows; Andrew+, a pipetting robot compatible with conventional electronic pipettes; Pipette, a cloud-enabled device to improve ergonomics and traceability; and Andrew, a portable liquid-handling robot that can operate unattended with manual pipettes. It also provides Andrew Assistant, a protocol-design software to create, verify, and document biology protocols that require quantitative liquid handling. Products are assembled and tested in Switzerland, with service and support based in Geneva and an office in Boston, and are sold directly and through distributor partners internationally. Founded in 2011, Andrew Alliance is an independent Swiss company that combines robotics, vision and software to enable researchers to perform precise, repeatable liquid-handling operations more efficiently, aiming to enhance accuracy and throughput in laboratory workflows.

Founded in 2010 by Nicolas Ecabert and Sylvain Melis, ecaVert is an engineering and consulting firm specializing in water and soil protection. The company develops and commercializes innovative solutions for live soil management, focusing on vertical green biobeds for water treatment.

Gourmetiz is an online platform that connects food producers to a range of consumers. The company was founded in 2011 and is headquartered in Geneve, Europe.

Stemergie Biotechnology, established in 2009 as a spin-off from the Geneva University Hospital and the University of Geneva, specializes in developing treatments and diagnostics for cancer by targeting cancer-initiating cells (CIC), which are considered the root cause of cancer. The company has created a proprietary technology platform that allows for the unbiased identification, validation, and development of treatments specifically aimed at brain CIC. This technology enables the isolation and enrichment of CIC without relying on specific markers. Stemergie has successfully identified and validated molecules that effectively eradicate brain CIC, and it aims to extend its technology to address other types of CIC, including those related to melanoma and other oncology indications. By combining its innovative treatments with existing standard therapies, Stemergie seeks to enhance the survival rates of patients with brain tumors and potentially transform cancer care.